drugset / Trial / NCT02736318
OD-PHOENIX in Talus Osteochondral Lesion
NaSingle-groupOpen-labelTreatment
Summary
Treatment of osteochondral lesion of Talus with a devitalized viro-inativated sterile osteochondral graft. To avoid having to harvest autograft material from the knee, a processed allogeneic osteochondral can be used instead autograft. The surgical technique is to implant in the osteochondral defect one to three products in the defect.
Timeline
- Start
- 2017-01-27
- Primary completion
- 2021-09-07
- Completion
- 2021-09-07
Outcome
Outcome not reported
Stopped (Enrollment): “Low accrual rate”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OD-PHOENIX | Other / unclassified | — | — |
Indications
No indication recorded.